These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 1574966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS.
    Ann Intern Med; 1992 Nov 01; 117(9):739-48. PubMed ID: 1416576
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R.
    Sangre (Barc); 1994 Apr 01; 39(2):105-10. PubMed ID: 8059287
    [Abstract] [Full Text] [Related]

  • 13. The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: a preliminary report.
    Chiou TJ, Chim YS, Wei CH, Hsieh RK, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov 01; 60(5):229-35. PubMed ID: 9509677
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Erythropoietin for anaemia in cancer patients.
    Abels R.
    Eur J Cancer; 1993 Nov 01; 29A Suppl 2():S2-8. PubMed ID: 8398361
    [No Abstract] [Full Text] [Related]

  • 16. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes.
    Adamson JW, Schuster M, Allen S, Haley NR.
    Acta Haematol; 1992 Nov 01; 87 Suppl 1():20-4. PubMed ID: 1574963
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin.
    Pangalis GA, Poziopoulos C, Angelopoulou MK, Siakantaris MP, Panayiotidis P.
    Br J Haematol; 1995 Mar 01; 89(3):627-9. PubMed ID: 7734364
    [Abstract] [Full Text] [Related]

  • 19. The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).
    Rose EH, Abels RI, Nelson RA, McCullough DM, Lessin L.
    Br J Haematol; 1995 Apr 01; 89(4):831-7. PubMed ID: 7772519
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin and the anaemia of chronic disease.
    Krantz SB.
    Nephrol Dial Transplant; 1995 Apr 01; 10 Suppl 2():10-7. PubMed ID: 7644100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.